<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               6 ADVERSE REACTIONS<BR>               <BR>                  The most serious adverse reactions from the use of letrozole are: <BR><BR>                  <BR>                     Bone effects [see Warnings and <BR>Precautions (5.1)].<BR>                     <BR>                     Increases in cholesterol [see Warnings and <BR>Precautions (5.2)].<BR>                     <BR>                  <BR>                  Because clinical trials are conducted under widely varying conditions, <BR>adverse reactions rates observed in the clinical trials of a drug cannot be <BR>directly compared to rates in the clinical trials of another drug and may not <BR>reflect the rates observed in practice.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        The most common adverse reactions (> 20%) were hot flashes, <BR>arthralgia (6.1); flushing, <BR>asthenia, edema, arthralgia, headache, dizziness, hypercholesterolemia, sweating <BR>increased, bone pain (6.2, 6.3); and <BR>musculoskeletal (6.4). <BR>                        <BR>                           To report SUSPECTED ADVERSE REACTIONS, contact Mylan <BR>Pharmaceuticals Inc. at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at <BR>1-800-FDA-1088 or www.fda.gov/medwatch. <BR>                        <BR>                        <BR><BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.1 Adjuvant Treatment of Early Breast Cancer<BR>                     <BR>                        The median treatment duration of adjuvant treatment was 60 months <BR>and the median duration of follow-up for safety was 73 months for patients <BR>receiving letrozole and tamoxifen. <BR>                        Certain adverse reactions were prospectively specified for analysis, based on <BR>the known pharmacologic properties and side effect profiles of the two drugs. <BR><BR>                        Adverse reactions were analyzed irrespective of whether a symptom was present <BR>or absent at baseline. Most adverse reactions reported (approximately 75% of <BR>patients reporting one or more AE) were Grade 1 or Grade 2 applying the Common <BR>Toxicity Criteria Version 2.0/ Common Terminology Criteria for Adverse Events, <BR>version 3.0. Table 1 describes adverse reactions (Grades 1 to 4) irrespective of <BR>relationship to study treatment in the adjuvant trial for the monotherapy arms <BR>analysis (safety population). <BR>                        <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="1" width="838" ID="i16e1b55f-aa26-408c-8d31-52d68ace41c5"><BR>                           <caption>Table 1: Patients with Adverse Reactions (CTC Grades 1 to 4, <BR>Irrespective of Relationship to Study Drug) in the Adjuvant Study &#8211; Monotherapy <BR>Arms Analysis (Median Follow-up 73 Months; Median Treatment 60 Months) <BR></caption><BR>                           <col width="31%"/><BR>                           <col width="16%"/><BR>                           <col width="17%"/><BR>                           <col width="17%"/><BR>                           <col width="17%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <content styleCode="bold">Grades <BR>1 to 4</content><BR>                                 </td><BR>                                 <td><BR>                                    <content styleCode="bold">Grades <BR>3 to 4</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Adverse <BR>Reaction </content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">N = 2,448</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">n (%)</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Tamoxifen</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">N = 2,447</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">n (%)</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">N = 2,448</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">n (%)</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Tamoxifen</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">N = 2,447</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">n (%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Pts with any adverse event </td><BR>                                 <td>2,310 (94.4) </td><BR>                                 <td>2,214 (90.5) </td><BR>                                 <td>635 (25.9) </td><BR>                                 <td>604 (24.7) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Hypercholesterolemia </td><BR>                                 <td>1,280 (52.3) </td><BR>                                 <td>700 (28.6) </td><BR>                                 <td>11 (0.4) </td><BR>                                 <td>6 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Hot Flashes/Flushes </td><BR>                                 <td>821 (33.5) </td><BR>                                 <td>929 (38) </td><BR>                                 <td>0 -</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Arthralgia/Arthritis </td><BR>                                 <td>618 (25.2) </td><BR>                                 <td>501 (20.4) </td><BR>                                 <td>85 (3.5) </td><BR>                                 <td>50 (2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Night Sweats </td><BR>                                 <td>357 (14.6) </td><BR>                                 <td>426 (17.4) </td><BR>                                 <td>0 -</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Bone Fractures<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>338 (13.8) </td><BR>                                 <td>257 (10.5) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Weight Increase </td><BR>                                 <td>317 (12.9) </td><BR>                                 <td>378 (15.4) </td><BR>                                 <td>27 (1.1) </td><BR>                                 <td>39 (1.6) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Nausea </td><BR>                                 <td>283 (11.6) </td><BR>                                 <td>277 (11.3) </td><BR>                                 <td>6 (0.2) </td><BR>                                 <td>9 (0.4) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Bone Fractures<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>247 (10.1) </td><BR>                                 <td>174 (7.1) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Fatigue (Lethargy, Malaise, <BR>Asthenia) </td><BR>                                 <td>235 (9.6) </td><BR>                                 <td>250 (10.2) </td><BR>                                 <td>6 (0.2) </td><BR>                                 <td>7 (0.3) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Myalgia </td><BR>                                 <td>217 (8.9) </td><BR>                                 <td>212 (8.7) </td><BR>                                 <td>18 (0.7) </td><BR>                                 <td>14 (0.6) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Edema </td><BR>                                 <td>164 (6.7) </td><BR>                                 <td>160 (6.5) </td><BR>                                 <td>3 (0.1) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Weight Decrease </td><BR>                                 <td>140 (5.7) </td><BR>                                 <td>129 (5.3) </td><BR>                                 <td>8 (0.3) </td><BR>                                 <td>5 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Vaginal Bleeding </td><BR>                                 <td>128 (5.2) </td><BR>                                 <td>320 (13.1) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                                 <td>8 (0.3) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Back Pain </td><BR>                                 <td>125 (5.1) </td><BR>                                 <td>136 (5.6) </td><BR>                                 <td>7 (0.3) </td><BR>                                 <td>11 (0.4) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Osteoporosis NOS </td><BR>                                 <td>124 (5.1) </td><BR>                                 <td>66 (2.7) </td><BR>                                 <td>10 (0.4) </td><BR>                                 <td>5 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Bone pain </td><BR>                                 <td>123 (5) </td><BR>                                 <td>109 (4.5) </td><BR>                                 <td>6 (0.2) </td><BR>                                 <td>4 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Depression </td><BR>                                 <td>119 (4.9) </td><BR>                                 <td>114 (4.7) </td><BR>                                 <td>16 (0.7) </td><BR>                                 <td>14 (0.6) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Vaginal Irritation </td><BR>                                 <td>111 (4.5) </td><BR>                                 <td>77 (3.1) </td><BR>                                 <td>2 (&lt; 0.1) </td><BR>                                 <td>2 (&lt; 0.1) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Headache </td><BR>                                 <td>105 (4.3) </td><BR>                                 <td>94 (3.8) </td><BR>                                 <td>9 (0.4) </td><BR>                                 <td>5 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Pain in extremity </td><BR>                                 <td>103 (4.2) </td><BR>                                 <td>79 (3.2) </td><BR>                                 <td>6 (0.2) </td><BR>                                 <td>4 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Osteopenia </td><BR>                                 <td>87 (3.6) </td><BR>                                 <td>74 (3) </td><BR>                                 <td>0 -</td><BR>                                 <td>2 (&lt; 0.1) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Dizziness/Light-Headedness </td><BR>                                 <td>84 (3.4) </td><BR>                                 <td>84 (3.4) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                                 <td>6 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Alopecia </td><BR>                                 <td>83 (3.4) </td><BR>                                 <td>84 (3.4) </td><BR>                                 <td>0 -</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Vomiting </td><BR>                                 <td>80 (3.3) </td><BR>                                 <td>80 (3.3) </td><BR>                                 <td>3 (0.1) </td><BR>                                 <td>5 (0.2) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Cataract </td><BR>                                 <td>49 (2) </td><BR>                                 <td>54 (2.2) </td><BR>                                 <td>16 (0.7) </td><BR>                                 <td>17 (0.7) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Constipation </td><BR>                                 <td>49 (2) </td><BR>                                 <td>71 (2.9) </td><BR>                                 <td>3 (0.1) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Breast pain </td><BR>                                 <td>37 (1.5) </td><BR>                                 <td>43 (1.8) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Anorexia </td><BR>                                 <td>20 (0.8) </td><BR>                                 <td>20 (0.8) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                                 <td>1 (&lt; 0.1) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Endometrial Hyperplasia/Cancer<linkHtml href="#footnote-1">*</linkHtml><BR>                                    <linkHtml href="#footnote-3">&#8225;</linkHtml><BR>                                 </td><BR>                                 <td>11/1,909 (0.6) </td><BR>                                 <td>70/1,943 (3.6) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Endometrial Proliferation <BR>Disorders </td><BR>                                 <td>10 (0.3) </td><BR>                                 <td>71 (1.8) </td><BR>                                 <td>0 -</td><BR>                                 <td>14 (0.6) </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Endometrial Hyperplasia/Cancer<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                    <linkHtml href="#footnote-3">&#8225;</linkHtml><BR>                                 </td><BR>                                 <td>6/1,909 (0.3) </td><BR>                                 <td>57/1,943 (2.9) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Other Endometrial Disorders </td><BR>                                 <td>2 (&lt; 0.1) </td><BR>                                 <td>3 (0.1) </td><BR>                                 <td>0 -</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Myocardial Infarction<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>24 (1) </td><BR>                                 <td>12 (0.5) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Myocardial Infarction<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>37 (1.5) </td><BR>                                 <td>25 (1) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Myocardial Ischemia </td><BR>                                 <td>6 (0.2) </td><BR>                                 <td>9 ( 0.4) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Cerebrovascular Accident<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>52 (2.1) </td><BR>                                 <td>46 (1.9) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Cerebrovascular Accident<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>70 (2.9) </td><BR>                                 <td>63 (2.6) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Angina<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>26 (1.1) </td><BR>                                 <td>24 (1) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Angina<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>32 (1.3) </td><BR>                                 <td>31 (1.3) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Thromboembolic Event<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>51 (2.1) </td><BR>                                 <td>89 (3.6) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Thromboembolic Event<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>71 (2.9) </td><BR>                                 <td>111 (4.5) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Other Cardiovascular<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>260 (10.6) </td><BR>                                 <td>256 (10.5) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Other Cardiovascular<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>312 (12.7) </td><BR>                                 <td>337 (13.8) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Second Malignancies<linkHtml href="#footnote-2">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>53 (2.2) </td><BR>                                 <td>78 (3.2) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>Second Malignancies<linkHtml href="#footnote-1">*</linkHtml><BR>                                 </td><BR>                                 <td>102 (4.2) </td><BR>                                 <td>119 (4.9) </td><BR>                                 <td>- -</td><BR>                                 <td>- -</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Note: Cardiovascular (including cerebrovascular and thromboembolic), skeletal <BR>and urogenital/endometrial events and second malignancies were collected <BR>life-long. All of these events were assumed to be of CTC grade 3 to 5 and were <BR>not individually graded.<BR>                        *Any time after randomization, including post treatment follow-up †During study treatment, based on Safety Monotherapy population‡Excluding women who had undergone hysterectomy before study en<BR><BR>                        <BR><BR>                        When considering all grades during study treatment, a higher incidence of <BR>events was seen for letrozole regarding fractures (10.1% vs. 7.1%), myocardial <BR>infarctions (1% vs. 0.5%), and arthralgia (25.2% vs. 20.4%) (letrozole vs. <BR>tamoxifen respectively). A higher incidence was seen for tamoxifen regarding <BR>thromboembolic events (2.1% vs. 3.6%), endometrial hyperplasia/cancer (0.3% vs. <BR>2.9%), and endometrial proliferation disorders (0.3% vs. 1.8%) (letrozole vs. <BR>tamoxifen respectively). <BR>                        At a median follow up of 73 months, a higher incidence of events was seen for <BR>letrozole (13.8%) than for tamoxifen (10.5%) regarding fractures. A higher <BR>incidence was seen for tamoxifen compared to letrozole regarding thromboembolic <BR>events (4.5% vs. 2.9%), and endometrial hyperplasia or cancer (2.9% vs. 0.4%) <BR>(tamoxifen vs. letrozole, respectively). <BR>                        <BR>                        <BR>                        Bone StudyResults of a phase 3 safety trial in 262 post menopausal women <BR>with resected receptor positive early breast cancer in the adjuvant setting <BR>comparing the effect on lumbar spine (L2 to L4) bone mineral density (BMD) of <BR>adjuvant treatment with letrozole to that with tamoxifen showed at 24 months a <BR>median decrease in lumbar spine BMD of 4.1% in the letrozole arm compared to a <BR>median increase of 0.3% in the tamoxifen arm (difference = 4.4%) (P < 0.0001). No patients with a normal BMD at baseline <BR>became osteoporotic over the 2 years and only one patient with osteopenia at <BR>baseline (T score of -1.9) developed osteoporosis during the treatment period <BR>(assessment by central review). The results for total hip BMD were similar, <BR>although the differences between the two treatments were less pronounced. During <BR>the 2-year period, fractures were reported by 4 of 103 patients (4%) in the <BR>letrozole arm and 6 of 97 patients (6%) in the tamoxifen arm. <BR>                        <BR>                        <BR>                        Lipid StudyIn a phase 3 safety trial in 262 post menopausal women with <BR>resected receptor positive early breast cancer at 24 months comparing the <BR>effects on lipid profiles of adjuvant letrozole to tamoxifen, 12% of patients on <BR>letrozole had at least one total cholesterol value of a higher CTCAE grade than <BR>at baseline compared with 4% of patients on tamoxifen.<BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.2 Extended Adjuvant Treatment of Early Breast Cancer, Median Treatment Duration of 24 Months<BR>                     <BR>                        The median duration of extended adjuvant treatment was 24 months <BR>and the median duration of follow-up for safety was 28 months for patients <BR>receiving letrozole and placebo. <BR>                        Table 2 describes the adverse reactions occurring at a frequency of at least <BR>5% in any treatment group during treatment. Most adverse reactions reported were <BR>Grade 1 and Grade 2 based on the Common Toxicity Criteria Version 2.0. In the <BR>extended adjuvant setting, the reported drug-related adverse reactions that were <BR>significantly different from placebo were hot flashes, arthralgia/arthritis and <BR>myalgia. <BR>                        <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="1" width="838" ID="ie67badba-1729-4f1c-86f4-3b24cfaf116b"><BR>                           <caption>Table 2: Percentage of Patients with Adverse Reactions </caption><BR>                           <col width="31%"/><BR>                           <col width="16%"/><BR>                           <col width="17%"/><BR>                           <col width="17%"/><BR>                           <col width="17%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <content styleCode="bold">Number <BR>(%) of Patients with <br/>Grade 1 to 4 Adverse Reaction</content><BR>                                 </td><BR>                                 <td><BR>                                    <content styleCode="bold">Number <BR>(%) of Patients with <br/>Grade 3 to 4 Adverse Reaction </content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole </content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = <BR>2,563</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Placebo </content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = <BR>2,573</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = <BR>2,563</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Placebo </content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">N = <BR>2,573</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Any Adverse <BR>Reaction </content><BR>                                 </td><BR>                                 <td>2,232 (87.1)</td><BR>                                 <td>2,174 (84.5)</td><BR>                                 <td>419 (16.3)</td><BR>                                 <td>389 (15.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Vascular <BR>Disorders </content><BR>                                 </td><BR>                                 <td>1,375 (53.6)</td><BR>                                 <td>1,230 (47.8)</td><BR>                                 <td>59 (2.3)</td><BR>                                 <td>74 (2.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Flushing </td><BR>                                 <td>1,273 (49.7)</td><BR>                                 <td>1,114 (43.3)</td><BR>                                 <td>3 (0.1)</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">General Disorders <BR></content><BR>                                 </td><BR>                                 <td>1,154 (45)</td><BR>                                 <td>1,090 (42.4)</td><BR>                                 <td>30 (1.2)</td><BR>                                 <td>28 (1.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Asthenia </td><BR>                                 <td>862 (33.6)</td><BR>                                 <td>826 (32.1)</td><BR>                                 <td>16 (0.6)</td><BR>                                 <td>7 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Edema NOS </td><BR>                                 <td>471 (18.4)</td><BR>                                 <td>416 (16.2)</td><BR>                                 <td>4 (0.2)</td><BR>                                 <td>3 (0.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Musculoskeletal <BR>Disorders </content><BR>                                 </td><BR>                                 <td>978 (38.2)</td><BR>                                 <td>836 (32.5)</td><BR>                                 <td>71 (2.8)</td><BR>                                 <td>50 (1.9)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Arthralgia </td><BR>                                 <td>565 (22)</td><BR>                                 <td>465 (18.1)</td><BR>                                 <td>25 (1)</td><BR>                                 <td>20 (0.8)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Arthritis NOS </td><BR>                                 <td>173 (6.7)</td><BR>                                 <td>124 (4.8)</td><BR>                                 <td>10 (0.4)</td><BR>                                 <td>5 (0.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Myalgia </td><BR>                                 <td>171 (6.7)</td><BR>                                 <td>122 (4.7)</td><BR>                                 <td>8 (0.3)</td><BR>                                 <td>6 (0.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Back Pain </td><BR>                                 <td>129 (5)</td><BR>                                 <td>112 (4.4)</td><BR>                                 <td>8 (0.3)</td><BR>                                 <td>7 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Nervous System <BR>Disorders </content><BR>                                 </td><BR>                                 <td>863 (33.7)</td><BR>                                 <td>819 (31.8)</td><BR>                                 <td>65 (2.5)</td><BR>                                 <td>58 (2.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Headache </td><BR>                                 <td>516 (20.1)</td><BR>                                 <td>508 (19.7)</td><BR>                                 <td>18 (0.7)</td><BR>                                 <td>17 (0.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Dizziness </td><BR>                                 <td>363 (14.2)</td><BR>                                 <td>342 (13.3)</td><BR>                                 <td>9 (0.4)</td><BR>                                 <td>6 (0.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Skin Disorders <BR></content><BR>                                 </td><BR>                                 <td>830 (32.4)</td><BR>                                 <td>787 (30.6)</td><BR>                                 <td>17 (0.7)</td><BR>                                 <td>16 (0.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Sweating Increased </td><BR>                                 <td>619 (24.2)</td><BR>                                 <td>577 (22.4)</td><BR>                                 <td>1 (&lt; 0.1)</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Gastrointestinal <BR>Disorders </content><BR>                                 </td><BR>                                 <td>725 (28.3)</td><BR>                                 <td>731 (28.4)</td><BR>                                 <td>43 (1.7)</td><BR>                                 <td>42 (1.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Constipation </td><BR>                                 <td>290 (11.3)</td><BR>                                 <td>304 (11.8)</td><BR>                                 <td>6 (0.2)</td><BR>                                 <td>2 (&lt; 0.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Nausea </td><BR>                                 <td>221 (8.6)</td><BR>                                 <td>212 (8.2)</td><BR>                                 <td>3 (0.1)</td><BR>                                 <td>10 (0.4)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Diarrhea NOS </td><BR>                                 <td>128 (5)</td><BR>                                 <td>143 (5.6)</td><BR>                                 <td>12 (0.5)</td><BR>                                 <td>8 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Metabolic <BR>Disorders </content><BR>                                 </td><BR>                                 <td>551 (21.5)</td><BR>                                 <td>537 (20.9)</td><BR>                                 <td>24 (0.9)</td><BR>                                 <td>32 (1.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Hypercholesterolemia </td><BR>                                 <td>401 (15.6)</td><BR>                                 <td>398 (15.5)</td><BR>                                 <td>2 (&lt; 0.1)</td><BR>                                 <td>5 (0.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Reproductive <BR>Disorders </content><BR>                                 </td><BR>                                 <td>303 (11.8)</td><BR>                                 <td>357 (13.9)</td><BR>                                 <td>9 (0.4)</td><BR>                                 <td>8 (0.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Vaginal Hemorrhage </td><BR>                                 <td>123 (4.8)</td><BR>                                 <td>171 (6.6)</td><BR>                                 <td>2 (&lt; 0.1)</td><BR>                                 <td>5 (0.2)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Vulvovaginal Dryness </td><BR>                                 <td>137 (5.3)</td><BR>                                 <td>127 (4.9)</td><BR>                                 <td>0 -</td><BR>                                 <td>0 -</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Psychiatric <BR>Disorders </content><BR>                                 </td><BR>                                 <td>320 (12.5)</td><BR>                                 <td>276 (10.7)</td><BR>                                 <td>21 (0.8)</td><BR>                                 <td>16 (0.6)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Insomnia </td><BR>                                 <td>149 (5.8)</td><BR>                                 <td>120 (4.7)</td><BR>                                 <td>2 (&lt; 0.1)</td><BR>                                 <td>2 (&lt; 0.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Respiratory <BR>Disorders </content><BR>                                 </td><BR>                                 <td>279 (10.9)</td><BR>                                 <td>260 (10.1)</td><BR>                                 <td>30 (1.2)</td><BR>                                 <td>28 (1.1)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Dyspnea </td><BR>                                 <td>140 (5.5)</td><BR>                                 <td>137 (5.3)</td><BR>                                 <td>21 (0.8)</td><BR>                                 <td>18 (0.7)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Investigations <BR></content><BR>                                 </td><BR>                                 <td>184 (7.2)</td><BR>                                 <td>147 (5.7)</td><BR>                                 <td>13 (0.5)</td><BR>                                 <td>13 (0.5)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Infections and <BR>Infestations </content><BR>                                 </td><BR>                                 <td>166 (6.5)</td><BR>                                 <td>163 (6.3)</td><BR>                                 <td>40 (1.6)</td><BR>                                 <td>33 (1.3)</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Renal <BR>Disorders </content><BR>                                 </td><BR>                                 <td>130 (5.1)</td><BR>                                 <td>100 (3.9)</td><BR>                                 <td>12 (0.5)</td><BR>                                 <td>6 <BR>(0.2)</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>Based on a median follow-up of patients for 28 months,the incidence of <BR>clinical fractures from the core randomized study in patients who received <BR>letrozole was 5.9% (152) and placebo was 5.5% (142). The incidence of <BR>self-reported osteoporosis was higher in patients who received letrozole 6.9% <BR>(176) than in patients who received placebo 5.5% (141). Bisphosphonates were <BR>administered to 21.1% of the patients who received letrozole and 18.7% of the <BR>patients who received placebo. <BR>                        The incidence of cardiovascular ischemic events from the core randomized <BR>study was comparable between patients who received letrozole 6.8% (175) and <BR>placebo 6.5% (167). <BR>                        A patient-reported measure that captures treatment impact on important <BR>symptoms associated with estrogen deficiency demonstrated a difference in favor <BR>of placebo for vasomotor and sexual symptom domains. <BR>                        <BR>                        <BR>                        Bone Sub-Study<BR>                           [see Warnings and <BR>Precautions (5.1)].<BR>                        <BR>                        <BR>                        <BR>                        Lipid Sub-StudyIn the extended adjuvant setting, based on a median duration of <BR>follow-up of 62 months, there was no significant difference between letrozole <BR>and placebo in total cholesterol or in any lipid fraction at any time over 5 <BR>years. Use of lipid lowering drugs or dietary management of elevated lipids was <BR>allowed [see Warnings and <BR>Precautions (5.2)].<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.3 Updated Analysis, Extended Adjuvant Treatment of Early Breast Cancer, Median Treatment Duration of 60 Months<BR>                     <BR>                        The extended adjuvant treatment trial was unblinded early [see Adverse Reactions <BR>(6.2)]. At the updated (final analysis), overall the side effects <BR>seen were consistent to those seen at a median treatment duration of 24 months. <BR><BR>                        During treatment or within 30 days of stopping treatment (median duration of <BR>treatment 60 months) a higher rate of fractures was observed for letrozole <BR>(10.4%) compared to placebo (5.8%), as also a higher rate of osteoporosis <BR>(letrozole 12.2% vs. placebo 6.4%). <BR>                        Based on 62 months median duration of follow-up in the randomized letrozole <BR>arm in the Safety population the incidence of new fractures at any time after <BR>randomization was 13.3% for letrozole and 7.8% for placebo. The incidence of new <BR>osteoporosis was 14.5% for letrozole and 7.8% for placebo. During treatment or <BR>within 30 days of stopping treatment (median duration of treatment 60 months) <BR>the incidence of cardiovascular events was 9.8% for letrozole and 7% for <BR>placebo. <BR>                        Based on 62 months median duration of follow-up in the randomized letrozole <BR>arm in the Safety population the incidence of cardiovascular disease at any time <BR>after randomization was 14.4% for letrozole and 9.8% for placebo. <BR>                        <BR>                        <BR>                        Lipid Sub-StudyIn the extended adjuvant setting, based on a median duration of <BR>follow-up of 62 months, there was no significant difference between letrozole <BR>and placebo in total cholesterol or in any lipid fraction over 5 years. Use of <BR>lipid lowering drugs or dietary management of elevated lipids was allowed [see Warnings and <BR>Precautions (5.2)]. <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.4 First-Line Treatment of Advanced Breast Cancer<BR>                     <BR>                        A total of 455 patients were treated for a median time of <BR>exposure of 11 months. The incidence of adverse reactions was similar for <BR>letrozole and tamoxifen. The most frequently reported adverse reactions were <BR>bone pain, hot flushes, back pain, nausea, arthralgia and dyspnea. <BR>Discontinuations for adverse reactions other than progression of tumor occurred <BR>in 10/455 (2%) of patients on letrozole and in 15/455 (3%) of patients on <BR>tamoxifen. <BR>                        Adverse reactions, regardless of relationship to study drug, that were <BR>reported in at least 5% of the patients treated with letrozole 2.5 mg or <BR>tamoxifen 20 mg in the first-line treatment study are shown in Table 3. <BR>                        <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="1" width="623" ID="i8062763a-3c50-48e8-8cca-d69b0e5a882c"><BR>                           <caption>Table 3: Percentage (%) of Patients with Adverse Reactions </caption><BR>                           <col width="53%"/><BR>                           <col width="23%"/><BR>                           <col width="23%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Adverse </content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">Reaction <BR></content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">2.5 mg</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">(N = 455)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Tamoxifen</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">20 mg</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">(N = 455)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">General <BR>Disorders</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Fatigue </td><BR>                                 <td>13</td><BR>                                 <td>13</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Chest Pain </td><BR>                                 <td>8</td><BR>                                 <td>9</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Edema Peripheral </td><BR>                                 <td>5</td><BR>                                 <td>6</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Pain NOS </td><BR>                                 <td>5</td><BR>                                 <td>7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Weakness</td><BR>                                 <td>6</td><BR>                                 <td>4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Investigations <BR></content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Weight Decreased</td><BR>                                 <td>7</td><BR>                                 <td>5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Vascular <BR>Disorders</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Hot Flushes </td><BR>                                 <td>19</td><BR>                                 <td>16</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Hypertension</td><BR>                                 <td>8</td><BR>                                 <td>4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Gastrointestinal <BR>Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Nausea </td><BR>                                 <td>17</td><BR>                                 <td>17</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Constipation </td><BR>                                 <td>10</td><BR>                                 <td>11</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Diarrhea </td><BR>                                 <td>8</td><BR>                                 <td>4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Vomiting </td><BR>                                 <td>7</td><BR>                                 <td>8</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Infections/Infestations</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Influenza </td><BR>                                 <td>6</td><BR>                                 <td>4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Urinary Tract Infection NOS <BR></td><BR>                                 <td>6</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Injury, Poisoning <BR>and Procedural Complications </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Post-Mastectomy Lymphedema </td><BR>                                 <td>7</td><BR>                                 <td>7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Metabolism and <BR>Nutrition Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Anorexia </td><BR>                                 <td>4</td><BR>                                 <td>6</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Musculoskeletal and <BR>Connective Tissue Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Bone Pain </td><BR>                                 <td>22</td><BR>                                 <td>21</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Back Pain </td><BR>                                 <td>18</td><BR>                                 <td>19</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Arthralgia </td><BR>                                 <td>16</td><BR>                                 <td>15</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Pain in Limb </td><BR>                                 <td>10</td><BR>                                 <td>8</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Nervous System <BR>Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Headache NOS </td><BR>                                 <td>8</td><BR>                                 <td>7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Psychiatric <BR>Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Insomnia </td><BR>                                 <td>7</td><BR>                                 <td>4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Reproductive System <BR>and Breast Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Breast Pain </td><BR>                                 <td>7</td><BR>                                 <td>7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Respiratory, <BR>Thoracic and Mediastinal Disorders </content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Dyspnea </td><BR>                                 <td>18</td><BR>                                 <td>17</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Cough </td><BR>                                 <td>13</td><BR>                                 <td>13</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Chest Wall Pain </td><BR>                                 <td>6</td><BR>                                 <td>6</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR> Other less frequent (≤ 2%) adverse reactions considered consequential for <BR>both treatment groups, included peripheral thromboembolic events, cardiovascular <BR>events and cerebrovascular events. Peripheral thromboembolic events included <BR>venous thrombosis, thrombophlebitis, portal vein thrombosis and pulmonary <BR>embolism. Cardiovascular events included angina, myocardial infarction, <BR>myocardial ischemia and coronary heart disease. Cerebrovascular events included <BR>transient ischemic attacks, thrombotic or hemorrhagic strokes and development of <BR>hemiparesis. <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.5 Second-Line Treatment of Advanced Breast Cancer<BR>                     <BR>                        Study discontinuations in the megestrol acetate comparison study <BR>for adverse reactions other than progression of tumor were 5/188 (2.7%) on <BR>letrozole 0.5 mg, in 4/174 (2.3%) on letrozole 2.5 mg, and in 15/190 (7.9%) on <BR>megestrol acetate. There were fewer thromboembolic events at both letrozole <BR>doses than on the megestrol acetate arm (0.6% vs. 4.7%). There was also less <BR>vaginal bleeding (0.3% vs. 3.2%) on letrozole than on megestrol acetate. In the <BR>aminoglutethimide comparison study, discontinuations for reasons other than <BR>progression occurred in 6/193 (3.1%) on 0.5 mg letrozole, 7/185 (3.8%) on 2.5 mg <BR>letrozole, and 7/178 (3.9%) of patients on aminoglutethimide. <BR>                        Comparisons of the incidence of adverse reactions revealed no significant <BR>differences between the high and low dose letrozole groups in either study. Most <BR>of the adverse reactions observed in all treatment groups were mild to moderate <BR>in severity and it was generally not possible to distinguish adverse reactions <BR>due to treatment from the consequences of the patient’s metastatic breast <BR>cancer, the effects of estrogen deprivation, or intercurrent illness. <BR>                        Adverse reactions, regardless of relationship to study drug, that were <BR>reported in at least 5% of the patients treated with letrozole 0.5 mg, letrozole <BR>2.5 mg, megestrol acetate, or aminoglutethimide in the two controlled trials are <BR>shown in Table 4. <BR>                        <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" border="1" width="804" ID="i844c6cac-5a76-4c2b-8650-61f79954ef5f"><BR>                           <caption>Table 4: Percentage (%) of Patients with Adverse Reactions </caption><BR>                           <col width="27%"/><BR>                           <col width="18%"/><BR>                           <col width="18%"/><BR>                           <col width="18%"/><BR>                           <col width="18%"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Adverse</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">Reaction</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Pooled</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">2.5 mg</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">(N = 359)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Pooled</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Letrozole</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">0.5 mg</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">(N = 380)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Megestrol</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Acetate</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">160 mg</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">(N = 189)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                                 <td><BR>                                    <paragraph><BR>                                       <content styleCode="bold">Aminoglutethimide</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">500 mg</content><BR>                                    </paragraph><BR>                                    <paragraph><BR>                                       <content styleCode="bold">(N = 178)</content><BR>                                    </paragraph><BR>                                    <content styleCode="bold">%</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Body as a <BR>Whole</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Fatigue</td><BR>                                 <td>8</td><BR>                                 <td>6</td><BR>                                 <td>11</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Chest Pain</td><BR>                                 <td>6</td><BR>                                 <td>3</td><BR>                                 <td>7</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Peripheral Edema<linkHtml href="#footnote-4">*</linkHtml><BR>                                 </td><BR>                                 <td>5</td><BR>                                 <td>5</td><BR>                                 <td>8</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Asthenia</td><BR>                                 <td>4</td><BR>                                 <td>5</td><BR>                                 <td>4</td><BR>                                 <td>5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Weight Increase</td><BR>                                 <td>2</td><BR>                                 <td>2</td><BR>                                 <td>9</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Cardiovascular</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Hypertension</td><BR>                                 <td>5</td><BR>                                 <td>7</td><BR>                                 <td>5</td><BR>                                 <td>6</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Digestive <BR>System</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Nausea</td><BR>                                 <td>13</td><BR>                                 <td>15</td><BR>                                 <td>9</td><BR>                                 <td>14</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Vomiting</td><BR>                                 <td>7</td><BR>                                 <td>7</td><BR>                                 <td>5</td><BR>                                 <td>9</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Constipation</td><BR>                                 <td>6</td><BR>                                 <td>7</td><BR>                                 <td>9</td><BR>                                 <td>7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Diarrhea</td><BR>                                 <td>6</td><BR>                                 <td>5</td><BR>                                 <td>3</td><BR>                                 <td>4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Pain-Abdominal</td><BR>                                 <td>6</td><BR>                                 <td>5</td><BR>                                 <td>9</td><BR>                                 <td>8</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Anorexia</td><BR>                                 <td>5</td><BR>                                 <td>3</td><BR>                                 <td>5</td><BR>                                 <td>5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Dyspepsia</td><BR>                                 <td>3</td><BR>                                 <td>4</td><BR>                                 <td>6</td><BR>                                 <td>5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Infections/Infestations</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Viral Infection</td><BR>                                 <td>6</td><BR>                                 <td>5</td><BR>                                 <td>6</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Lab <BR>Abnormality</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Hypercholesterolemia</td><BR>                                 <td>3</td><BR>                                 <td>3</td><BR>                                 <td>0</td><BR>                                 <td>6</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Musculoskeletal <BR>System</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Musculoskeletal<linkHtml href="#footnote-5">&#8224;</linkHtml><BR>                                 </td><BR>                                 <td>21</td><BR>                                 <td>22</td><BR>                                 <td>30</td><BR>                                 <td>14</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Arthralgia</td><BR>                                 <td>8</td><BR>                                 <td>8</td><BR>                                 <td>8</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Nervous <BR>System</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Headache</td><BR>                                 <td>9</td><BR>                                 <td>12</td><BR>                                 <td>9</td><BR>                                 <td>7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Somnolence</td><BR>                                 <td>3</td><BR>                                 <td>2</td><BR>                                 <td>2</td><BR>                                 <td>9</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Dizziness</td><BR>                                 <td>3</td><BR>                                 <td>5</td><BR>                                 <td>7</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Respiratory <BR>System</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Dyspnea</td><BR>                                 <td>7</td><BR>                                 <td>9</td><BR>                                 <td>16</td><BR>                                 <td>5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Coughing</td><BR>                                 <td>6</td><BR>                                 <td>5</td><BR>                                 <td>7</td><BR>                                 <td>5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td><BR>                                    <content styleCode="bold">Skin and <BR>Appendages</content><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                                 <td><BR>                                    <br/><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Hot Flushes</td><BR>                                 <td>6</td><BR>                                 <td>5</td><BR>                                 <td>4</td><BR>                                 <td>3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Rash<linkHtml href="#footnote-6">&#8225;</linkHtml><BR>                                 </td><BR>                                 <td>5</td><BR>                                 <td>4</td><BR>                                 <td>3</td><BR>                                 <td>12</td><BR>                              </tr><BR>                              <tr><BR>                                 <td>&#160;&#160;&#160;&#160;&#160;Pruritus</td><BR>                                 <td>1</td><BR>                                 <td>2</td><BR>                                 <td>5</td><BR>                                 <td>3</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR> <BR>                        *Includes peripheral edema, leg edema, dependent edema, edema.†Includes musculoskeletal pain, skeletal pain, back pain, arm pain, leg pain.‡Includes rash, erythematous rash, maculopapular rash, psoriasiform rash, <BR>vesicular rash.<BR><BR>                        <BR>Other less frequent (< 5%) adverse reactions considered consequential and <BR>reported in at least three patients treated with letrozole, included <BR>hypercalcemia, fracture, depression, anxiety, pleural effusion, alopecia, <BR>increased sweating and vertigo. <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.6 First and Second-Line Treatment of Advanced Breast Cancer<BR>                     <BR>                        In the combined analysis of the first- and second-line metastatic <BR>trials and post-marketing experiences other adverse reactions that were reported <BR>were cataract, eye irritation, palpitations, cardiac failure, tachycardia, <BR>dysesthesia (including hypesthesia/paresthesia), arterial thrombosis, memory <BR>impairment, irritability, nervousness, urticaria, increased urinary frequency, <BR>leukopenia, stomatitis cancer pain, pyrexia, vaginal discharge, appetite <BR>increase, dryness of skin and mucosa (including dry mouth), and disturbances of <BR>taste and thirst. <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.7 Post-Marketing Experience<BR>                     <BR>                        Cases of blurred vision, increased hepatic enzymes, angioedema, <BR>anaphylactic reactions, toxic epidermal necrolysis, erythema multiforme and <BR>hepatitis have been reported. <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>